using the update rate determined by the market’s variations, assuming the asset will remain
the same and in the same place. The net cash flows cannot include financial or fiscal
payments, or cash flows used for reproducing biological assets after the harvest. In this case,
the company can conduct an independent external evaluation for determining the value using
planned cash flows.
Value estimation based on market prices
In the circumstances where there is no active market for the evaluated asset, one must
check for prices determined by market variations. The market prices are the most recent
transaction prices, and the market prices for similar products or sector prices are transferred to
production capacity. The biological assets and agricultural produce are often sold through
future goods contracts. According to IASB, the buying prices established by these contracts
don’t necessarily reflect the real market price, that is why is doesn’t correspond to an
evaluation criterion for biological assets and agricultural produce.
Purchase or production costs and determining the updated value
Estimated point-of-sale costs
The estimated point-of-sale costs will be subtracted from the fair value, and added to
commercial factorages, public payments or taxes for goods exchange markets. These costs do
not include transportation expenses or similar expenses. They must be considered when
calculating the asset’s fair value.